ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,64
-0,92%
Dow Jones
39 806,77
-0,49%
DAX
18 700,85
-0,35%
Brent Oil
82,41
-1,34%
Bitcoin
71 026,16
-0,59%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gemini Therapeutics Inc (GMTX)

  7. Gemini Therapeutics Inc (GMTX) Actualités

GMTX

Gemini Therapeutics (GMTX)

Gemini Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GMTX
DateHeureSourceTitreSymboleSociété
29/06/202322h18Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
28/06/202323h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GMTXGemini Therapeutics Inc
21/06/202322h54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
20/06/202322h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GMTXGemini Therapeutics Inc
16/06/202313h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
15/06/202312h26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GMTXGemini Therapeutics Inc
15/05/202313h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GMTXGemini Therapeutics Inc
20/04/202313h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GMTXGemini Therapeutics Inc
20/04/202313h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GMTXGemini Therapeutics Inc
31/03/202313h20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GMTXGemini Therapeutics Inc
24/02/202322h48Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GMTXGemini Therapeutics Inc
25/01/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GMTXGemini Therapeutics Inc
18/01/202312h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GMTXGemini Therapeutics Inc
18/01/202312h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GMTXGemini Therapeutics Inc
09/01/202322h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GMTXGemini Therapeutics Inc
09/01/202322h03Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GMTXGemini Therapeutics Inc
27/12/202214h56Dow Jones NewsGemini Therapeutics Shares Rise After Disc Medicine Gets FDA DesignationNASDAQ:GMTXGemini Therapeutics Inc
27/12/202214h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GMTXGemini Therapeutics Inc
27/12/202214h00PR Newswire (US)Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic ProtoporphyriaNASDAQ:GMTXGemini Therapeutics Inc
31/10/202214h00PR Newswire (US)Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)NASDAQ:GMTXGemini Therapeutics Inc
02/09/202223h11Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GMTXGemini Therapeutics Inc
10/08/202213h30Business WireGemini Therapeutics and Disc Medicine Announce Merger AgreementNASDAQ:GMTXGemini Therapeutics Inc
22/07/202211h39TipRanksGemini Therapeutics (GMTX) Gets a Hold Rating from SVB SecuritiesNASDAQ:GMTXGemini Therapeutics Inc
11/03/202212h08Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GMTXGemini Therapeutics Inc
10/03/202213h00Business WireGemini Therapeutics Reports 2021 Financial ResultsNASDAQ:GMTXGemini Therapeutics Inc
10/03/202200h16Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GMTXGemini Therapeutics Inc
28/02/202214h37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GMTXGemini Therapeutics Inc
28/02/202214h30Business WireGemini Therapeutics Provides Corporate UpdateNASDAQ:GMTXGemini Therapeutics Inc
04/02/202214h02Edgar (US Regulatory)Schedule 13gNASDAQ:GMTXGemini Therapeutics Inc
10/01/202214h00Business WireGemini Therapeutics Provides GEM103 Program UpdateNASDAQ:GMTXGemini Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GMTX

Dernières Valeurs Consultées

EU
GLE
Societe Generale
EU
HO
Thales
COIN
BTCUSD
Bitcoin
EU
RI
Pernod Ricard
NYSE
DIS
Walt Disney
EU
PX4
SBF 120
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
EU
VIV
Vivendi
EU
BEL20
Bel 20
SPI
SP500
S&P 500
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés